| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |